Table 2.
Patients according to distance from the hippocampus of the closest metastasis.
| <5mm | 5 to <10mm | 10 to <15mm | ≥15mm | |
|---|---|---|---|---|
| Primary Site | ||||
| NSCLC | 14 (9.0%) | 20 (12.9) | 22 (14.2) | 99 (63.9) |
| SCLC | 4 (10.5) | 5 (13.2) | 10 (26.3) | 19 (50) |
| Breast | 4 (6.3) | 9 (14.3) | 11 (17.5) | 39 (61.9) |
| Melanoma | 7 (14.9) | 5 (10.6) | 3 (6.4) | 32 (68.1) |
| Renal | 0 | 0 | 2 (13.3) | 13 (86.7) |
| Other | 3 (5.7) | 6 (11.3) | 6 (11.3) | 38 (71.7) |
| Aggregate Number of Metastases | ||||
| 1 | 10 (6.7%) | 10 (6.7) | 11 (7.4) | 118 (79.2) |
| 2 | 7 (8.9) | 9 (11.4) | 14 (17.7) | 49 (62.0) |
| 3 | 7 (15.9) | 5 (11.4) | 7 (15.9) | 25 (56.8) |
| ≥4 | 8 (8.1) | 21 (21.2) | 22 (22.2) | 48 (48.5) |
| Aggregate Volume of Metastases | ||||
| ≤ Median* | 9 (4.9%) | 15 (8.1) | 23 (12.4) | 138 (74.6) |
| > Median* | 23 (12.4) | 30 (16.1) | 31 (16.7) | 102 (54.8) |
| Total | 32 (8.6%) | 45 (12.1) | 54 (14.5) | 240 (64.7) |
Abbreviations: NSCLC, non-small-cell lung cancer, SCLC, small cell lung cancer.
*
Median aggregate volume of intracranial metastases = 4.9 cm3
Percent of patients within each row given parenthetically.